Literature DB >> 10881769

Recurrent coagulopathy after antivenom treatment of crotalid snakebite.

G M Bogdan1, R C Dart, S C Falbo, J McNally, D Spaite.   

Abstract

BACKGROUND: We studied whether recurrence of coagulopathy, defined as the return of a coagulation abnormality after initial normalization, occurred after the use of antivenin (Crotalidae) polyvalent.
METHODS: A retrospective, blinded, descriptive analysis of 354 consecutive cases of North American crotalid snake envenomation was done. Inclusion criteria were documented clinical evidence of crotalid snakebite, presence of a coagulopathy (platelet count <150,000/mm3, prothrombin time above normal, or fibrinogen level <150 mg/dL), and treatment with antivenin (Crotalidae) polyvalent.
RESULTS: Of 112 cases with a coagulopathy extending beyond 6 hours after envenomation, 31 had sufficient coagulopathy testing to detect recurrence. Fourteen of these patients (45%) had recurrence of coagulopathy, and two cases were severe (fibrinogen level 29 mg/dL; platelet count 36,000/mm3).
CONCLUSION: Recurrence of coagulopathy after envenomation by North American crotalid snakes may occur after use of antivenin (Crotalidae) polyvalent and can result in severe coagulation abnormalities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881769

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  7 in total

Review 1.  Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.

Authors:  José María Gutiérrez; Guillermo León; Bruno Lomonte
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

2.  Persistent coagulopathy in snake bite.

Authors:  Alka Khadwal; Bhavneet Bharti; Banani Poddar; Srikant Basu; Virender Singh Virdi; Veena Parmar
Journal:  Indian J Pediatr       Date:  2003-05       Impact factor: 1.967

3.  Fatality in a case of envenomation by Crotalus adamanteus initially successfully treated with polyvalent ovine antivenom followed by recurrence of defibrinogenation syndrome.

Authors:  Craig Kitchens; Thomas Eskin
Journal:  J Med Toxicol       Date:  2008-09

4.  The role for coagulation markers in mild snakebite envenomations.

Authors:  Risa S Moriarity; Sylvia Dryer; William Replogle; Richard L Summers
Journal:  West J Emerg Med       Date:  2012-02

5.  Recurrent coagulopathy after rattlesnake bite requiring continuous intravenous dosing of antivenom.

Authors:  Charles W Hwang; F Eike Flach
Journal:  Case Rep Emerg Med       Date:  2015-01-12

Review 6.  Crotaline Fab antivenom appears to be effective in cases of severe North American pit viper envenomation: an integrative review.

Authors:  Eric J Lavonas; Tammi H Schaeffer; Jamie Kokko; Sara L Mlynarchek; Gregory M Bogdan
Journal:  BMC Emerg Med       Date:  2009-06-22

7.  Dosage comparison of snake anti-venomon coagulopathy.

Authors:  Ali Hassan Rahmani; Amir Jalali; Mohammad Hassan Alemzadeh-Ansari; Mina Tafazoli; Fakher Rahim
Journal:  Iran J Pharm Res       Date:  2014       Impact factor: 1.696

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.